S Tsiara, M Elisaf, DP Mikhailidis - Current Medical Research and Opinion®, 2003 - informahealthcare.com Large-scale trials established that statin administration in
hypercholesterolaemic individuals and patients with coronary heart disease (CHD)
significantly reduces the risk of vascular events and death. This benefit ... Cited by 146 - Related articles - BL Direct - All 6 versions
PN Durrington, J Tuomilehto, A Hamann, D … - Diabetes research and clinical practice, 2004 - Elsevier The aim of this study was to evaluate the effects of rosuvastatin and
fenofibrate alone and in combination in type 2 diabetes associated with combined
hyperlipidaemia. A total of 216 patients with total cholesterol ≥200 ... Cited by 68 - Related articles - All 8 versions
DW Erkelens - The American journal of cardiology, 2001 - Elsevier Patients with type 2 diabetes mellitus have an elevated risk of morbidity and
mortality from cardiovascular disease. This risk is partly attributable to an
increased prevalence of classic coronary artery disease risk factors and ... Cited by 56 - Related articles - BL Direct - All 7 versions
HN Ginsberg - The American Journal of Cardiology, 2001 - Elsevier It has long been recognized that elevated triglyceride levels are associated
with increased risk for coronary heart disease (CHD). However, it has not been
determined whether elevated triglycerides are an independent risk factor ... Cited by 36 - Related articles - BL Direct - All 6 versions
D Zambón, E Ros, C Rodriguez-Villar, JC … - Metabolism, 1999 - Elsevier The most appropriate therapy for combined hyperlipidemia remains to be
determined. We compared the lipid-regulating effects of gemfibrozil and
lovastatin in 30 patients with familial combined hyperlipidemia (FCHL) in a ... Cited by 34 - Related articles - BL Direct - All 10 versions
DJ Rader, SM Haffner - The American journal of cardiology, 1999 - Elsevier A growing body of evidence indicates that hypertriglyceridemia is an independent
risk factor for cardiovascular disease.[1] However, not all patients with
elevated triglyceride levels are at increased risk of coronary artery ... Cited by 34 - Related articles - BL Direct - All 6 versions
JA Papadakis, HJ Milionis, M Press, DP … - Journal of diabetes and its complications, 2001 - Elsevier Patients with non-insulin-dependent diabetes (NIDDM) have an increased incidence
of ischaemic heart disease (IHD) when compared with nondiabetic subjects. In
addition, they have a worse prognosis after their first myocardial ... Cited by 30 - Related articles - BL Direct - All 11 versions
M Farnier, S Picard - Current Atherosclerosis Reports, 2001 - Springer Introduction The prevalence of diabetes mellitus, especially type 2 diabetes, is
increasing worldwide. Coronary heart disease (CHD) is the leading cause of
mortality in people with diabetes and the risk of CHD is increased about ... Cited by 22 - Related articles - All 2 versions
WP Battisti, J Palmisano, WF Keane - Clinical chemistry and laboratory medicine, 2003 - reference-global.com Type 2 diabetes mellitus is a leading cause of morbid- ity and mortality.
Cardiovascular disease (CVD) is the most prevalent complication and primarily
accounts for the excess morbidity and mortality in diabetic pa- tients, but ... Cited by 20 - Related articles - BL Direct - All 6 versions
C Rustemeijer, JA Schouten, HJ Voerman, H … - Diabetes/Metabolism Reviews - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 20 - Related articles - BL Direct - All 4 versions
